The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Observational retrospective study to describe the management of advanced epidermal growth factor receptor (EGFR) mutated (M+) non-small cell lung cancer (NSCLC) patients (pts) in Spain (NCT01795352).
Edurne Arriola
No relevant relationships to disclose
Ramon Garcia Gomez
No relevant relationships to disclose
Pilar Diz
No relevant relationships to disclose
Margarita Majem
No relevant relationships to disclose
Maite Martinez Aguillo
No relevant relationships to disclose
Javier Valdivia
No relevant relationships to disclose
Alfredo Paredes
No relevant relationships to disclose
Jose Miguel Sanchez Torres
No relevant relationships to disclose
Sergi Peralta
No relevant relationships to disclose
Isidoro C. Barneto
No relevant relationships to disclose
Maria Carmen Gonzalez-Arenas
Employment or Leadership Position - AstraZeneca